A SYNTHETIC HYDROGEL AND ITS USE FOR IMMUNOTHERAPY AND 3D-PRINTING

Patent number:

EP20382432

Cataluña.svg
No items found.

The present invention discloses a hydrogel comprising a functionalized PEG multi- arm star polymer covalently combined with maleimide-functionalized low molecular weight heparin, further comprising at least one positively charged immune molecule, a method for producing this hydrogel and its use in T cell culture for immunotherapies. Furthermore, the invention relates to a bioink and its use in 3D-(bio)-printing.

Countries:
Spain
Regions:
Catalonia
Centers:
FUNDACIO INST DE BIOENGINYERIA DE CATALUNYA IBEC, CSIC, CT DE INVESTIGACIO BIOMEDICA EN RED DE ENFERMEDADES RARAS CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS, UNIVERSITAT POLITECNICA DE CATALUNYA
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

Hydrogel formed with poly(ethylene)glycol (PEG) combined with heparin and a positively charged immune molecule, ands its use in T cell culture and immunotherapies.

Comments

Other related patents

Health

NANOREP®: NEW TECHNOLOGY FOR THE EASY AND SAFE HANDLING OF OOCYTES AND EMBRYO

Countries
Spain
Know more
Health

Photosensitizer, Pharmaceutical Composition Compounding It, and Its Use in Photodynamic Therapy

Countries
Spain
Know more
Health

Improved glucose monitoring during exercise using wearable devices

Countries
Spain
Know more
Get back to patents directory